Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies. Under the proposed transaction, Mirati Therapeutics shareholders will receive $58.00 in cash and a CVR of up to $12.00 per share. Under the proposed transaction BigBear.ai will acquire Pangiam for approximately $70 million in an all-stock transaction. Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. Moore Kuehn pays all case costs and does not charge its investor clients.
Source: The Bubble November 15, 2023 19:03 UTC